We are glad to announce that dorsaVi has entered into a master services agreement (MSA) with Medtronic which progresses the commercial relationship between the two companies. The initial statement of work (SOW) under the agreement is worth approximately US$330k to dorsaVi and is expected to run for approximately 12 months, involving the collaborative data analysis, tailoring and application of dorsaVi’s technology.

For more information click here